Biolife Solutions Share Price (NASDAQ: BLFS)

$25.05

▲

0.13

(0.52%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Biolife Solutions Stock chart to analyse performance

Biolife Solutions stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$24.89
Today's High:$25.20
$25.05
0.64%
Downside
Day's Volatility :1.23%
Upside
0.6%
52 Weeks Low:$19.10
52 Weeks High:$29.55
$25.05
23.75%
Downside
52 Weeks Volatility :35.35%
Upside
15.21%

Biolife Solutions Stock Returns

Period	Biolife Solutions, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	20.98%	3.6%	0.0%
6 Months	2.12%	-7.7%	0.0%
1 Year	2.46%	-12.6%	0.0%
3 Years	5.52%	9.5%	-4.7%

Biolife Solutions, Inc. Key Stats

Check Biolife Solutions key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$24.92
Open	$25.22
Today's High	$25.2
Today's Low	$24.89
Market Capitalization	$1.2B
Today's Volume	$354.5K
52 Week High	$29.545
52 Week Low	$19.1
Revenue TTM	$93.5M
EBITDA	$-1.3M
Earnings Per Share (EPS)	$-0.4
Profit Margin	-5.92%
Quarterly Earnings Growth YOY	6.4%
Return On Equity TTM	-5.66%

Stock Returns calculator for Biolife Solutions Stock including INR - Dollar returns

The Biolife Solutions stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Biolife Solutions investment value today

Current value as on today

₹1,02,077

Returns

₹2,077

(+2.08%)

Returns from Biolife Solutions Stock

₹3,207 (-3.21%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Biolife Solutions Stock

40%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Biolife Solutions Stock from India on INDmoney has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Biolife Solutions, Inc.

Name
Holdings %
Name
Holdings %
Casdin Capital, LLC
16.11%
BlackRock Inc
11.44%
T. Rowe Price Investment Management,Inc.
8.88%
Amvescap Plc.
7.42%
Vanguard Group Inc
6.06%
Fred Alger Management, LLC
3.21%

Analyst Recommendation on Biolife Solutions Stock

Rating

Trend

Buy

86%Buy

13%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Biolife Solutions(by analysts ranked 0 to 5 stars)

Biolife Solutions Share Price Target

What analysts predicted

Upside of 24.95%

Target:

$31.30

Current:

$25.05

Biolife Solutions share price target is $31.30, a slight Upside of 24.95% compared to current price of $25.05 as per analysts' prediction.

Biolife Solutions Stock Insights

Price Movement
In the last 7 days, BLFS stock has moved down by -3.4%
Increasing Revenue
Revenue is up for the last 3 quarters, -3.42M → 25.42M (in $), with an average increase of 60.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 12.45M → -15.83M (in $), with an average decrease of 1769.4% per quarter
BLFS vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 12.2% return, outperforming this stock by 15.5%
BLFS vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 25.2% return, outperforming this stock by 18.6%
Price to Sales
ForBLFS every $1 of sales, investors are willing to pay $12.6, whereas for Resmed Inc., the investors are paying $7.8 for every $1 of sales.

Biolife Solutions, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$27.4M	↑ 38.64%
Net Income	$-1.7M	↓ 150.73%
Net Profit Margin	-6.05%	↓ 22.59%

	FY20	Y/Y Change
Revenue	$48.1M	↑ 75.69%
Net Income	$2.7M	↓ 260.95%
Net Profit Margin	5.55%	↑ 11.6%

	FY21	Y/Y Change
Revenue	$119.2M	↑ 147.79%
Net Income	$-8.9M	↓ 434.01%
Net Profit Margin	-7.48%	↓ 13.03%

	FY22	Y/Y Change
Revenue	$76.2M	↓ 36.02%
Net Income	$-139.8M	↑ 1469.43%
Net Profit Margin	-183.38%	↓ 175.9%

	FY23	Y/Y Change
Revenue	$143.3M	↑ 87.92%
Net Income	$-66.4M	↓ 52.49%
Net Profit Margin	-46.36%	↑ 137.02%

	FY24	Y/Y Change
Revenue	$82.3M	↓ 42.59%
Net Income	$-20.2M	↓ 69.61%
Net Profit Margin	-24.54%	↑ 21.82%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$18.4M	↓ 43.69%
Net Income	$-10.2M	↓ 23.63%
Net Profit Margin	-55.45%	↓ 14.56%

	Q2 FY24	Q/Q Change
Revenue	$28.3M	↑ 53.68%
Net Income	$-20.7M	↑ 102.71%
Net Profit Margin	-73.14%	↓ 17.69%

	Q3 FY24	Q/Q Change
Revenue	$30.6M	↑ 7.92%
Net Income	$-1.7M	↓ 91.78%
Net Profit Margin	-5.57%	↑ 67.57%

	Q4 FY24	Q/Q Change
Revenue	$-3.4M	↓ 111.2%
Net Income	$12.5M	↓ 831.59%
Net Profit Margin	-363.87%	↓ 358.3%

	Q1 FY25	Q/Q Change
Revenue	$23.9M	↓ 799.21%
Net Income	$-448.0K	↓ 103.6%
Net Profit Margin	-1.87%	↑ 362.0%

	Q2 FY25	Q/Q Change
Revenue	$25.4M	↑ 6.18%
Net Income	$-15.8M	↑ 3435.27%
Net Profit Margin	-62.3%	↓ 60.43%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$18.5M	↑ 36.88%

	FY20	Y/Y Change
Profit	$27.4M	↑ 48.23%

	FY21	Y/Y Change
Profit	$37.7M	↑ 37.56%

	FY22	Y/Y Change
Profit	$53.8M	↑ 42.58%

	FY23	Y/Y Change
Profit	$46.8M	↓ 13.14%

	FY24	Y/Y Change
Profit	$53.7M	↑ 14.8%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$11.6M	↑ 39.72%

	Q2 FY24	Q/Q Change
Profit	$14.9M	↑ 27.87%

	Q3 FY24	Q/Q Change
Profit	$21.8M	↑ 46.42%

	Q4 FY24	Q/Q Change
Profit	$8.3M	↓ 62.07%

	Q1 FY25	Q/Q Change
Profit	$15.8M	↑ 90.86%

	Q2 FY25	Q/Q Change
Profit	$17.4M	↑ 10.14%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.2M	↓ 48.34%
Investing Cash Flow	$-27.0M	↑ 315.66%
Financing Cash Flow	$1.6M	↓ 94.33%

	FY20	Y/Y Change
Operating Cash Flow	$6.5M	↑ 437.1%
Investing Cash Flow	$-23.7M	↓ 12.17%
Financing Cash Flow	$102.1M	↑ 6295.86%

	FY21	Y/Y Change
Operating Cash Flow	$-4.8M	↓ 174.23%
Investing Cash Flow	$-12.6M	↓ 46.73%
Financing Cash Flow	$-2.8M	↓ 102.72%

	FY22	Y/Y Change
Operating Cash Flow	$-8.5M	↑ 75.54%
Investing Cash Flow	$-58.1M	↑ 359.71%
Financing Cash Flow	$16.3M	↓ 687.37%

	FY23	Y/Y Change
Operating Cash Flow	$-12.5M	↑ 47.23%
Investing Cash Flow	$17.8M	↓ 130.69%
Financing Cash Flow	$10.6M	↓ 35.09%

	FY24	Y/Y Change
Operating Cash Flow	$8.4M	↓ 167.46%
Investing Cash Flow	$58.3M	↑ 226.85%
Financing Cash Flow	$-6.8M	↓ 164.04%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-4.5M	↓ 293.64%
Investing Cash Flow	$-221.0K	↓ 105.59%
Financing Cash Flow	$-952.0K	↓ 109.67%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$6.5M	↓ 244.34%
Investing Cash Flow	$-13.4M	↑ 5979.19%
Financing Cash Flow	$-704.0K	↓ 26.05%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$4.8M	↓ 25.65%
Investing Cash Flow	$-1.7M	↓ 87.49%
Financing Cash Flow	$-1.0M	↑ 47.87%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$1.6M	↓ 65.74%
Investing Cash Flow	$73.6M	↓ 4480.55%
Financing Cash Flow	$-4.1M	↑ 292.51%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$1.7M	↑ 4.98%
Investing Cash Flow	$-27.2M	↓ 136.91%
Financing Cash Flow	$-3.0M	↓ 26.77%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$7.4M	↑ 326.64%
Investing Cash Flow	$-39.5M	↑ 45.47%
Financing Cash Flow	$-2.9M	↓ 3.81%

Biolife Solutions Technicals Summary

Sell

Neutral

Buy

Biolife Solutions is currently in a neutral trading position according to technical analysis indicators.

Biolife Solutions, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biolife Solutions, Inc.	20.31%	2.12%	2.46%	5.52%	10.41%
Intuitive Surgical, Inc.	-2.14%	-16.61%	-2.2%	129.39%	91.27%
Alcon Ag	-9.17%	-15.22%	-16.6%	20.12%	40.07%
West Pharmaceutical Services Inc	3.24%	8.32%	-18.78%	-16.58%	-12.33%
Resmed Inc.	-1.56%	17.91%	12.23%	25.22%	53.62%
Becton, Dickinson And Company	9.36%	-15.57%	-20.36%	-24.43%	-19.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biolife Solutions, Inc.	NA	NA	65.38	0.04	-0.06	-0.01	NA	7.26
Intuitive Surgical, Inc.	66.27	66.27	3.47	8.14	0.16	0.09	NA	49.79
Alcon Ag	36.78	36.78	2.16	3.1	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	36.74	36.74	3.55	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	28.99	28.99	1.9	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.34	35.34	0.96	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biolife Solutions, Inc.	Buy	$1.2B	10.41%	NA	-5.92%
Intuitive Surgical, Inc.	Buy	$169.9B	91.27%	66.27	28.51%
Alcon Ag	Buy	$39.3B	40.07%	36.78	10.7%
West Pharmaceutical Services Inc	Buy	$17.7B	-12.33%	36.74	16.48%
Resmed Inc.	Buy	$40.3B	53.62%	28.99	27.22%
Becton, Dickinson And Company	Buy	$55.3B	-19.91%	35.34	7.41%

About Biolife Solutions, Inc.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Organization	Biolife Solutions
Employees	159
CEO	Mr. Roderick de Greef
Industry	Health Technology

Key Management of Biolife Solutions, Inc.

Name	Title
Mr. Roderick de Greef	CEO & Chairman
Ms. Karen Foster	Chief Quality & Operations Officer
Dr. Aby J. Mathew Ph.D.	Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer
Mr. Todd Berard	Chief Commercial Officer
Mr. Sean Werner Ph.D.	Chief Technology Officer
Ms. Sarah Aebersold J.D.	Chief Human Resources Officer

Important FAQs about investing in BLFS Stock from India :

What is Biolife Solutions share price today?

Biolife Solutions share price today is $25.05 as on August 30, 2025 at 1:29 am IST at the close of the market. Biolife Solutions share today touched a day high of $25.20 and a low of $24.89.

What is the 52 week high and 52 week low for Biolife Solutions share?

Biolife Solutions share touched a 52 week high of $29.55 and a 52 week low of $19.10. Biolife Solutions stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $25.05, lower by 15.21% versus the 52 week high.

How to invest in Biolife Solutions Stock (BLFS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biolife Solutions on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biolife Solutions Shares that will get you 0.0599 shares as per Biolife Solutions share price of $25.05 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Biolife Solutions Stock (BLFS) from India?

Indian investors can start investing in Biolife Solutions (BLFS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Biolife Solutions stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Biolife Solutions share’s latest price of $25.05 as on August 30, 2025 at 1:29 am IST, you will get 0.3992 shares of Biolife Solutions. Learn more about fractional shares .

What are the returns that Biolife Solutions has given to Indian investors in the last 5 years?

Biolife Solutions stock has given 10.41% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?